Get started
Author

Irit Avni‐Biron

Observed names: I Avni-Biron, I. Avni-Biron, I., Avni-Biron, Irit Avni Biron, Irit Avni-Biron, Irit Avni‐biron
ORCID: 0000-0001-9142-6530
Observed ORCID: 0000-0001-9142-6530
OpenAlex ID: A5024970715
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection
2016 · Miguel Regueiro, Brian G. Feagan, et al. · Gastroenterology · 339
PDF
Risankizumab for Ulcerative Colitis
2024 · Edouard Louis, Stefan Schreiber, et al. · JAMA · 134
PDF
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience
2017 · Uri Kopylov, Yulia Ron, et al. · Inflammatory Bowel Diseases · 101
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
2021 · Silvio Danese, Jean-Frederic Colombel, et al. · ˜The œLancet. Gastroenterology & hepatology · 98
PDF
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
2021 · Laurent Peyrin-Biroulet, Ailsa Hart, et al. · ˜The œLancet. Gastroenterology & hepatology · 97
PDF
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
2021 · Hadar Edelman-Klapper, Eran Zittan, et al. · Gastroenterology · 95
PDF
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study
2018 · Uri Kopylov, Bram Verstockt, et al. · Inflammatory Bowel Diseases · 71
Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study
2022 · Henit Yanai, Anna Kagramanova, et al. · Journal of Crohn s and Colitis · 64
PDF
Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study
2019 · Ariella Bar-Gil Shitrit, Ami Ben Ya'acov, et al. · The American Journal of Gastroenterology · 63
Probiotics and prebiotics in Crohn's disease therapies
2016 · Lev Lichtenstein, Irit Avni-Biron, et al. · Best Practice & Research Clinical Gastroenterology · 53
Mechanistic Implications of the Mediterranean Diet in Patients With Newly Diagnosed Crohn's Disease: Multiomic Results From a Prospective Cohort
2025 · Lihi Godny, Sarine Elial-Fatal, et al. · Gastroenterology · 44
Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study
2022 · Irit Avni‐Biron, Tali Mishael, et al. · Alimentary Pharmacology & Therapeutics · 38
Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: A multicenter Israeli study
2020 · Ariella Bar‐Gil Shitrit, Ami Ben‐Ya’acov, et al. · United European Gastroenterology Journal · 36
PDF
Environmental Factors Associated With Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project
2024 · Mingyue Xue, Haim Leibovitzh, et al. · Clinical Gastroenterology and Hepatology · 35
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience
2018 · Uri Kopylov, Irit Avni-Biron, et al. · Digestive and Liver Disease · 35
Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes
2020 · Jacob E. Ollech, Irit Avni-Biron, et al. · Clinical Gastroenterology and Hepatology · 20
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel
2021 · Irit Avni-Biron, Ariella Bar-Gil Shitrit, et al. · Digestive and Liver Disease · 19
Immune function in newborns with in-utero exposure to anti-TNFα therapy
2022 · Batia Weiss, Shomron Ben-Horin, et al. · Frontiers in Pediatrics · 17
PDF
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases
2022 · Keren Rabinowitz, Michal Navon, et al. · Vaccines · 17
PDF
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study
2022 · Aurelien Amiot, Jean-Francois Rahier, et al. · Journal of Crohn s and Colitis · 15
PDF
Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn’s Disease: A Pilot Study
2017 · Liran Domachevsky, Haim Leibovitzh, et al. · Contrast Media & Molecular Imaging · 13
PDF
The current place of probiotics and prebiotics in the treatment of pouchitis
2016 · Lev Lichtenstein, Irit Avni-Biron, et al. · Best Practice & Research Clinical Gastroenterology · 13
Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study
2024 · Jacob E. Ollech, Hagar Eran-Banai, et al. · Annals of Medicine · 12
A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn’s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes
2023 · Henit Yanai, Tali Sharar Fischler, et al. · Crohn s & Colitis 360 · 11
PDF
Multidisciplinary Perinatal Care in IBD
2022 · Lihi Godny, Vaios Svolos, et al. · Journal of Crohn s and Colitis · 11
PDF
Works count: 95
Citation count: 1,564
H-index: 17
I10-index: 27
Year
Topic
Type